"At Clinical Research Prime we are always on the lookout for two things: 1) patients who could benefit from our studies and 2) new studies that could provide additional treatment options for patients. As a volunteer in one of our studies, you would receive all treatments and medical care related to the trial at no cost. If you would like to learn more, please see our upcoming and current studies."

During the past decade, Clinical Research Prime conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 7 clinical trials were completed, i.e. on average, 17.1% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 7 clinical trials were completed. i.e. 20.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Prime" #1 sponsor was "Pfizer" with 9 trials, followed by "Abbott Nutrition" with 5 trials sponsored, "GTx" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "ModernaTX, Inc." with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Prime" #1 collaborator was "Paidion Research, Inc." with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "Health Decisions" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Prime" are "Gastro-Intestinal Tolerance" (3 trials), "Influenza" (3 trials), "Pneumococcal Disease" (3 trials), "Stress Urinary Incontinence" (3 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Clinical Research Prime" in a lesser frequency.

Most popular intervention types in "Clinical Research Prime" are "Drug" (17 trials), "Biological" (16 trials), "Other" (12 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Baloxavir Marboxil" (3 trials), "Control Infant Formula" (3 trials), "Experimental Infant Formula" (3 trials) and "13-valent pneumococcal conjugate vaccine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Prime" are 25 trials for "All" genders and 17 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Prime". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Clinical Research Prime, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Prime, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".